General Information of Drug (ID: DMX4GND)

Drug Name
Meperidine
Synonyms
Demarol; Demerol; Dolcontral; Dolosal; Dolsin; Isonipecain; Isonipecaine; Lidol; Lydol; Meperidol; Nemerol; Pethanol; Pethidin; Pethidine; Pethidineter; Pethidinum; Petidina; Petydyna; Phetidine; Piperosal; Pipersal; Meperidine solution; Methyl phenylpiperidine carbonic acid ethyl ester; Operidine EPJ I; Pethidine DBL; Petydyna [Polish]; Demerol (TN); Operidine EPJ-I; Pethidine (INN); Pethidine DBL (TN); Pethidinum [INN-Latin]; Petidina [INN-Spanish]; Ethyl 1-methyl-4-phenylisonipecotate; Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate; N-Methyl-4-phenyl-4-carbethoxypiperidine; Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester; YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI); 1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester; 1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester; 1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German]; 1-Methyl-4-phenylisonipecotic acid, ethyl ester;1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester; 4-Carbethoxy-1-methyl-4-phenylpiperidine; 4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester
Indication
Disease Entry ICD 11 Status REF
Pain MG30-MG3Z Approved [1]
Therapeutic Class
Anesthetics
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 247.33
Logarithm of the Partition Coefficient (xlogp) 2.5
Rotatable Bond Count (rotbonds) 4
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 3
ADMET Property
BDDCS Class
Biopharmaceutics Drug Disposition Classification System (BDDCS) Class 1: high solubility and high permeability [2]
Clearance
The drug present in the plasma can be removed from the body at the rate of 4.9 mL/min/kg [3]
Elimination
13% of drug is excreted from urine in the unchanged form [2]
Half-life
The concentration or amount of drug in body reduced by one-half in 3 - 5 hours [3]
Metabolism
The drug is metabolized via the liver []
MRTD
The Maximum Recommended Therapeutic Dose (MRTD) of drug that ensured maximising efficacy and moderate side effect is 60.64524 micromolar/kg/day [4]
Unbound Fraction
The unbound fraction of drug in plasma is 0.42% [3]
Vd
Fluid volume that would be required to contain the amount of drug present in the body at the same concentration as in the plasma 2.3 L/kg [3]
Water Solubility
The ability of drug to dissolve in water is measured as 3.22 mg/mL [2]
Chemical Identifiers
Formula
C15H21NO2
IUPAC Name
ethyl 1-methyl-4-phenylpiperidine-4-carboxylate
Canonical SMILES
CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
InChI
InChI=1S/C15H21NO2/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3
InChIKey
XADCESSVHJOZHK-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
4058
ChEBI ID
CHEBI:6754
CAS Number
57-42-1
DrugBank ID
DB00454
TTD ID
D00UYE
VARIDT ID
DR00016
INTEDE ID
DR1024
ACDINA ID
D00397
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Adrenergic receptor Alpha-2 (ADRA2) TTQ8AFT NOUNIPROTAC Agonist [5]

Drug Transporter (DTP)
DTP Name DTP ID UniProt ID MOA REF
P-glycoprotein 1 (ABCB1) DTUGYRD MDR1_HUMAN Substrate [6]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytochrome P450 3A4 (CYP3A4) DE4LYSA CP3A4_HUMAN Substrate [7]
Cytochrome P450 2D6 (CYP2D6) DECB0K3 CP2D6_HUMAN Substrate [8]
Mephenytoin 4-hydroxylase (CYP2C19) DEGTFWK CP2CJ_HUMAN Substrate [9]
Cytochrome P450 2B6 (CYP2B6) DEPKLMQ CP2B6_HUMAN Substrate [10]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Drug-Drug Interaction (DDI) Information of This Drug

Coadministration of a Drug Treating the Same Disease as Meperidine
DDI Drug Name DDI Drug ID Severity Mechanism Disease REF
Pentazocine DM1XBHS Major Additive CNS depression effects by the combination of Meperidine and Pentazocine. Pain [MG30-MG3Z] [11]
Dextropropoxyphene DM23HCX Major Additive CNS depression effects by the combination of Meperidine and Dextropropoxyphene. Pain [MG30-MG3Z] [12]
Butorphanol DM5KYPJ Major Additive CNS depression effects by the combination of Meperidine and Butorphanol. Pain [MG30-MG3Z] [11]
Oxymorphone DM65AGJ Major Additive CNS depression effects by the combination of Meperidine and Oxymorphone. Pain [MG30-MG3Z] [13]
Levorphanol DMGS80V Major Additive CNS depression effects by the combination of Meperidine and Levorphanol. Pain [MG30-MG3Z] [13]
Dezocine DMJDB0Y Major Additive CNS depression effects by the combination of Meperidine and Dezocine. Pain [MG30-MG3Z] [11]
Flavoxate DMKV4NL Moderate Additive antimotility effects by the combination of Meperidine and Flavoxate. Pain [MG30-MG3Z] [14]
Nalbuphine DMOSQGU Major Additive hypotensive effects by the combination of Meperidine and Nalbuphine. Pain [MG30-MG3Z] [11]
Buprenorphine DMPRI8G Major Additive CNS depression effects by the combination of Meperidine and Buprenorphine. Pain [MG30-MG3Z] [11]
Hydrocodone DMQ2JO5 Major Additive CNS depression effects by the combination of Meperidine and Hydrocodone. Pain [MG30-MG3Z] [13]
Oxycodone DMXLKHV Major Additive CNS depression effects by the combination of Meperidine and Oxycodone. Pain [MG30-MG3Z] [13]
⏷ Show the Full List of 11 DDI Information of This Drug
Coadministration of a Drug Treating the Disease Different from Meperidine (Comorbidity)
DDI Drug Name DDI Drug ID Severity Mechanism Comorbidity REF
Methylene blue DMJAPE7 Major Additive serotonergic effects by the combination of Meperidine and Methylene blue. Acquired methaemoglobinaemia [3A93] [15]
Oliceridine DM6MDCF Major Additive CNS depression effects by the combination of Meperidine and Oliceridine. Acute pain [MG31] [13]
Marinol DM70IK5 Moderate Additive CNS depression effects by the combination of Meperidine and Marinol. Anorexia nervosa [6B80] [16]
Buspirone DMBS632 Major Additive serotonergic effects by the combination of Meperidine and Buspirone. Anxiety disorder [6B00-6B0Z] [17]
Methylphenobarbital DMDSWAG Major Additive CNS depression effects by the combination of Meperidine and Methylphenobarbital. Anxiety disorder [6B00-6B0Z] [18]
Hydroxyzine DMF8Y74 Major Additive CNS depression effects by the combination of Meperidine and Hydroxyzine. Anxiety disorder [6B00-6B0Z] [13]
Halazepam DMPFWO6 Major Additive CNS depression effects by the combination of Meperidine and Halazepam. Anxiety disorder [6B00-6B0Z] [13]
Chlordiazepoxide DMTN5XI Major Additive CNS depression effects by the combination of Meperidine and Chlordiazepoxide. Anxiety disorder [6B00-6B0Z] [13]
Chlormezanone DMTWUXR Major Additive CNS depression effects by the combination of Meperidine and Chlormezanone. Anxiety disorder [6B00-6B0Z] [13]
Oxazepam DMXNZM4 Major Additive CNS depression effects by the combination of Meperidine and Oxazepam. Anxiety disorder [6B00-6B0Z] [13]
Desipramine DMT2FDC Major Additive serotonergic effects by the combination of Meperidine and Desipramine. Attention deficit hyperactivity disorder [6A05] [19]
Linezolid DMGFPU2 Major Additive serotonergic effects by the combination of Meperidine and Linezolid. Bacterial infection [1A00-1C4Z] [20]
Retigabine DMGNYIH Moderate Additive CNS depression effects by the combination of Meperidine and Retigabine. Behcet disease [4A62] [16]
Lamotrigine DM8SXYG Moderate Additive CNS depression effects by the combination of Meperidine and Lamotrigine. Bipolar disorder [6A60] [16]
Cariprazine DMJYDVK Major Additive CNS depression effects by the combination of Meperidine and Cariprazine. Bipolar disorder [6A60] [13]
Loperamide DMOJZQ9 Moderate Additive CNS depression effects by the combination of Meperidine and Loperamide. Bowel habit change [ME05] [21]
Alpelisib DMEXMYK Moderate Increased metabolism of Meperidine caused by Alpelisib mediated induction of CYP450 enzyme. Breast cancer [2C60-2C6Y] [22]
Dihydrocodeine DMB0FWL Major Additive CNS depression effects by the combination of Meperidine and Dihydrocodeine. Chronic pain [MG30] [18]
Levetiracetam DMTGDN8 Moderate Additive CNS depression effects by the combination of Meperidine and Levetiracetam. Chronic pain [MG30] [16]
Levobupivacaine DM783CH Minor Increased plasma concentration of Meperidine and Levobupivacaine due to competitive binding of plasma proteins. Corneal disease [9A76-9A78] [23]
Propofol DMB4OLE Moderate Additive cardiorespiratory depression effects by the combination of Meperidine and Propofol. Corneal disease [9A76-9A78] [24]
Ketamine DMT5HA4 Moderate Additive CNS depression effects by the combination of Meperidine and Ketamine. Corneal disease [9A76-9A78] [16]
Ethanol DMDRQZU Moderate Additive CNS depression effects by the combination of Meperidine and Ethanol. Cystitis [GC00] [25]
Sertraline DM0FB1J Major Additive serotonergic effects by the combination of Meperidine and Sertraline. Depression [6A70-6A7Z] [19]
Trimipramine DM1SC8M Major Additive serotonergic effects by the combination of Meperidine and Trimipramine. Depression [6A70-6A7Z] [19]
Cyclobenzaprine DM1YBRM Major Additive serotonergic effects by the combination of Meperidine and Cyclobenzaprine. Depression [6A70-6A7Z] [17]
Imipramine DM2NUH3 Major Additive serotonergic effects by the combination of Meperidine and Imipramine. Depression [6A70-6A7Z] [19]
Fluoxetine DM3PD2C Major Additive serotonergic effects by the combination of Meperidine and Fluoxetine. Depression [6A70-6A7Z] [19]
Nortriptyline DM4KDYJ Major Additive serotonergic effects by the combination of Meperidine and Nortriptyline. Depression [6A70-6A7Z] [19]
Vilazodone DM4LECQ Major Additive serotonergic effects by the combination of Meperidine and Vilazodone. Depression [6A70-6A7Z] [19]
Nefazodone DM4ZS8M Major Additive serotonergic effects by the combination of Meperidine and Nefazodone. Depression [6A70-6A7Z] [19]
Paroxetine DM5PVQE Major Additive serotonergic effects by the combination of Meperidine and Paroxetine. Depression [6A70-6A7Z] [19]
Selegiline DM6034S Major Additive serotonergic effects by the combination of Meperidine and Selegiline. Depression [6A70-6A7Z] [15]
Duloxetine DM9BI7M Major Additive serotonergic effects by the combination of Meperidine and Duloxetine. Depression [6A70-6A7Z] [19]
Isocarboxazid DMAF1NB Major Additive serotonergic effects by the combination of Meperidine and Isocarboxazid. Depression [6A70-6A7Z] [15]
Milnacipran DMBFE74 Major Additive serotonergic effects by the combination of Meperidine and Milnacipran. Depression [6A70-6A7Z] [19]
Escitalopram DMFK9HG Major Additive serotonergic effects by the combination of Meperidine and Escitalopram. Depression [6A70-6A7Z] [19]
Tranylcypromine DMGB5RE Major Additive serotonergic effects by the combination of Meperidine and Tranylcypromine. Depression [6A70-6A7Z] [15]
Desvenlafaxine DMHD4PE Major Additive serotonergic effects by the combination of Meperidine and Desvenlafaxine. Depression [6A70-6A7Z] [19]
OPC-34712 DMHG57U Major Additive CNS depression effects by the combination of Meperidine and OPC-34712. Depression [6A70-6A7Z] [13]
Phenelzine DMHIDUE Major Additive serotonergic effects by the combination of Meperidine and Phenelzine. Depression [6A70-6A7Z] [15]
Clomipramine DMINRKW Major Additive serotonergic effects by the combination of Meperidine and Clomipramine. Depression [6A70-6A7Z] [19]
Trazodone DMK1GBJ Major Additive serotonergic effects by the combination of Meperidine and Trazodone. Depression [6A70-6A7Z] [19]
Amoxapine DMKITQE Major Additive serotonergic effects by the combination of Meperidine and Amoxapine. Depression [6A70-6A7Z] [19]
Doxepin DMPI98T Major Additive serotonergic effects by the combination of Meperidine and Doxepin. Depression [6A70-6A7Z] [19]
Maprotiline DMPWB7T Moderate Additive CNS depression effects by the combination of Meperidine and Maprotiline. Depression [6A70-6A7Z] [16]
Esketamine DMVU687 Moderate Additive CNS depression effects by the combination of Meperidine and Esketamine. Depression [6A70-6A7Z] [26]
Mepenzolate DM8YU2F Moderate Additive CNS depression effects by the combination of Meperidine and Mepenzolate. Digestive system disease [DE2Z] [14]
Oxybutynine DMJPBAX Moderate Additive CNS depression effects by the combination of Meperidine and Oxybutynine. Discovery agent [N.A.] [14]
Heroin diacetylmorphine DMDBWHY Major Additive CNS depression effects by the combination of Meperidine and Heroin diacetylmorphine. Dissociative neurological symptom disorder [6B60] [18]
Fenfluramine DM0762O Major Additive serotonergic effects by the combination of Meperidine and Fenfluramine. Epilepsy/seizure [8A61-8A6Z] [19]
Diazepam DM08E9O Major Additive CNS depression effects by the combination of Meperidine and Diazepam. Epilepsy/seizure [8A61-8A6Z] [13]
Zonisamide DM0DTF7 Moderate Additive CNS depression effects by the combination of Meperidine and Zonisamide. Epilepsy/seizure [8A61-8A6Z] [16]
Primidone DM0WX6I Major Increased metabolism of Meperidine caused by Primidone mediated induction of CYP450 enzyme. Epilepsy/seizure [8A61-8A6Z] [21]
Felbamate DM1V5ZS Moderate Additive CNS depression effects by the combination of Meperidine and Felbamate. Epilepsy/seizure [8A61-8A6Z] [16]
Oxcarbazepine DM5PU6O Moderate Additive CNS depression effects by the combination of Meperidine and Oxcarbazepine. Epilepsy/seizure [8A61-8A6Z] [16]
Mephenytoin DM5UGDK Moderate Increased metabolism of Meperidine caused by Mephenytoin mediated induction of CYP450 enzyme. Epilepsy/seizure [8A61-8A6Z] [27]
Gabapentin DM6T924 Major Additive CNS depression effects by the combination of Meperidine and Gabapentin. Epilepsy/seizure [8A61-8A6Z] [28]
Cenobamate DM8KLU9 Moderate Additive CNS depression effects by the combination of Meperidine and Cenobamate. Epilepsy/seizure [8A61-8A6Z] [16]
Tiagabine DMKSQG0 Moderate Additive CNS depression effects by the combination of Meperidine and Tiagabine. Epilepsy/seizure [8A61-8A6Z] [16]
Stiripentol DMMSDOY Moderate Additive CNS depression effects by the combination of Meperidine and Stiripentol. Epilepsy/seizure [8A61-8A6Z] [16]
Phenacemide DMOHS9P Moderate Additive CNS depression effects by the combination of Meperidine and Phenacemide. Epilepsy/seizure [8A61-8A6Z] [16]
Fosphenytoin DMOX3LB Moderate Increased metabolism of Meperidine caused by Fosphenytoin mediated induction of CYP450 enzyme. Epilepsy/seizure [8A61-8A6Z] [27]
Paramethadione DMR5ZUP Moderate Additive CNS depression effects by the combination of Meperidine and Paramethadione. Epilepsy/seizure [8A61-8A6Z] [16]
Clonazepam DMTO13J Major Additive CNS depression effects by the combination of Meperidine and Clonazepam. Epilepsy/seizure [8A61-8A6Z] [13]
Lacosamide DMVM6QR Moderate Additive CNS depression effects by the combination of Meperidine and Lacosamide. Epilepsy/seizure [8A61-8A6Z] [16]
Rufinamide DMWE60C Moderate Additive CNS depression effects by the combination of Meperidine and Rufinamide. Epilepsy/seizure [8A61-8A6Z] [16]
Ethotoin DMXWOCP Moderate Increased metabolism of Meperidine caused by Ethotoin mediated induction of CYP450 enzyme. Epilepsy/seizure [8A61-8A6Z] [27]
Phenobarbital DMXZOCG Major Additive CNS depression effects by the combination of Meperidine and Phenobarbital. Epilepsy/seizure [8A61-8A6Z] [21]
Vigabatrin DMYT0OG Moderate Additive CNS depression effects by the combination of Meperidine and Vigabatrin. Epilepsy/seizure [8A61-8A6Z] [16]
Carbamazepine DMZOLBI Moderate Additive CNS depression effects by the combination of Meperidine and Carbamazepine. Epilepsy/seizure [8A61-8A6Z] [16]
Cannabidiol DM0659E Moderate Additive CNS depression effects by the combination of Meperidine and Cannabidiol. Epileptic encephalopathy [8A62] [16]
Dantrolene DM1D8XY Major Additive CNS depression effects by the combination of Meperidine and Dantrolene. Fever [MG26] [13]
Solifenacin DMG592Q Moderate Additive CNS depression effects by the combination of Meperidine and Solifenacin. Functional bladder disorder [GC50] [14]
Tolterodine DMSHPW8 Moderate Additive CNS depression effects by the combination of Meperidine and Tolterodine. Functional bladder disorder [GC50] [14]
Propantheline DM2EN6G Moderate Additive CNS depression effects by the combination of Meperidine and Propantheline. Gastric ulcer [DA60] [14]
Cimetidine DMH61ZB Moderate Decreased metabolism of Meperidine caused by Cimetidine mediated inhibition of CYP450 enzyme. Gastro-oesophageal reflux disease [DA22] [29]
Brimonidine DMQLT4N Moderate Additive CNS depression effects by the combination of Meperidine and Brimonidine. Glaucoma [9C61] [30]
Isoniazid DM5JVS3 Moderate Additive hypotensive effects by the combination of Meperidine and Isoniazid. HIV-infected patients with tuberculosis [1B10-1B14] [31]
Procarbazine DMIK367 Major Additive serotonergic effects by the combination of Meperidine and Procarbazine. Hodgkin lymphoma [2B30] [15]
Suvorexant DM0E6S3 Major Additive CNS depression effects by the combination of Meperidine and Suvorexant. Insomnia [7A00-7A0Z] [13]
Ramelteon DM7IW9J Major Additive CNS depression effects by the combination of Meperidine and Ramelteon. Insomnia [7A00-7A0Z] [13]
Flurazepam DMAL4G0 Major Additive CNS depression effects by the combination of Meperidine and Flurazepam. Insomnia [7A00-7A0Z] [13]
Triazolam DMETYK5 Major Additive CNS depression effects by the combination of Meperidine and Triazolam. Insomnia [7A00-7A0Z] [13]
Zaleplon DMGFWSM Major Additive CNS depression effects by the combination of Meperidine and Zaleplon. Insomnia [7A00-7A0Z] [13]
Propiomazine DMKY8V1 Major Additive CNS depression effects by the combination of Meperidine and Propiomazine. Insomnia [7A00-7A0Z] [13]
Tasimelteon DMLOQ1V Major Additive CNS depression effects by the combination of Meperidine and Tasimelteon. Insomnia [7A00-7A0Z] [13]
Paraldehyde DMOC1BX Major Additive CNS depression effects by the combination of Meperidine and Paraldehyde. Insomnia [7A00-7A0Z] [13]
ITI-007 DMUQ1DO Major Additive CNS depression effects by the combination of Meperidine and ITI-007. Insomnia [7A00-7A0Z] [13]
Nabilone DMVRYT2 Moderate Additive CNS depression effects by the combination of Meperidine and Nabilone. Insomnia [7A00-7A0Z] [16]
Quazepam DMY4D87 Major Additive CNS depression effects by the combination of Meperidine and Quazepam. Insomnia [7A00-7A0Z] [13]
Estazolam DMZGXUM Major Additive CNS depression effects by the combination of Meperidine and Estazolam. Insomnia [7A00-7A0Z] [13]
Polyethylene glycol DM4I1JP Moderate Increased risk of lowers seizure threshold by the combination of Meperidine and Polyethylene glycol. Irritable bowel syndrome [DD91] [32]
Clidinium DMUMQZ0 Moderate Additive antimotility effects by the combination of Meperidine and Clidinium. Irritable bowel syndrome [DD91] [14]
Dicyclomine DMZSDGX Moderate Additive antimotility effects by the combination of Meperidine and Dicyclomine. Irritable bowel syndrome [DD91] [14]
Remimazolam DMLVSYX Major Additive CNS depression effects by the combination of Meperidine and Remimazolam. Labour/delivery anaesthesia complication [JB0C] [13]
PF-06463922 DMKM7EW Moderate Increased metabolism of Meperidine caused by PF-06463922 mediated induction of CYP450 enzyme. Lung cancer [2C25] [26]
Allopregnanolone DMNLHAC Moderate Additive CNS depression effects by the combination of Meperidine and Allopregnanolone. Mental/behavioural/neurodevelopmental disorder [6E20-6E8Z] [33]
Dexmedetomidine DM93L4X Moderate Additive CNS depression effects by the combination of Meperidine and Dexmedetomidine. Mood/affect symptom [MB24] [16]
Midazolam DMXOELT Moderate Additive CNS depression effects by the combination of Meperidine and Midazolam. Mood/affect symptom [MB24] [16]
Thalidomide DM70BU5 Moderate Additive CNS depression effects by the combination of Meperidine and Thalidomide. Multiple myeloma [2A83] [34]
Prasugrel DM7MT6E Moderate Altered absorption of Meperidine due to GI dynamics variation caused by Prasugrel. Myocardial infarction [BA41-BA43] [35]
Promethazine DM6I5GR Moderate Additive CNS depression effects by the combination of Meperidine and Promethazine. Nausea/vomiting [MD90] [16]
Metoclopramide DMFA5MY Moderate Antagonize the effect of Meperidine when combined with Metoclopramide. Nausea/vomiting [MD90] [36]
Granisetron DMIUW25 Major Additive serotonergic effects by the combination of Meperidine and Granisetron. Nausea/vomiting [MD90] [37]
Dolasetron DMMG26Z Major Additive serotonergic effects by the combination of Meperidine and Dolasetron. Nausea/vomiting [MD90] [37]
Ondansetron DMOTQ1I Major Additive serotonergic effects by the combination of Meperidine and Ondansetron. Nausea/vomiting [MD90] [37]
E-2007 DMJDYNQ Moderate Additive CNS depression effects by the combination of Meperidine and E-2007. Neuropathy [8C0Z] [16]
Bupropion DM5PCS7 Major Increased risk of lowers seizure threshold by the combination of Meperidine and Bupropion. Nicotine use disorder [6C4A] [38]
Sibutramine DMFJTDI Major Additive serotonergic effects by the combination of Meperidine and Sibutramine. Obesity [5B80-5B81] [39]
Lorcaserin DMG6OYJ Major Additive serotonergic effects by the combination of Meperidine and Lorcaserin. Obesity [5B80-5B81] [40]
Dexfenfluramine DMJ7YDS Major Additive serotonergic effects by the combination of Meperidine and Dexfenfluramine. Obesity [5B80-5B81] [19]
Levomethadyl Acetate DM06HG5 Major Additive CNS depression effects by the combination of Meperidine and Levomethadyl Acetate. Opioid use disorder [6C43] [18]
Apraclonidine DMO4PVE Moderate Additive CNS depression effects by the combination of Meperidine and Apraclonidine. Optic nerve disorder [9C40] [30]
Olaparib DM8QB1D Moderate Increased metabolism of Meperidine caused by Olaparib mediated induction of CYP450 enzyme. Ovarian cancer [2C73] [26]
Safinamide DM0YWJC Major Additive serotonergic effects by the combination of Meperidine and Safinamide. Parkinsonism [8A00] [15]
Rasagiline DM3WKQ4 Major Additive serotonergic effects by the combination of Meperidine and Rasagiline. Parkinsonism [8A00] [15]
Biperiden DME78OA Moderate Additive CNS depression effects by the combination of Meperidine and Biperiden. Parkinsonism [8A00] [41]
Pimavanserin DMR7IVC Major Additive CNS depression effects by the combination of Meperidine and Pimavanserin. Parkinsonism [8A00] [13]
Orphenadrine DMW542E Major Additive CNS depression effects by the combination of Meperidine and Orphenadrine. Parkinsonism [8A00] [13]
Abametapir DM2RX0I Moderate Decreased metabolism of Meperidine caused by Abametapir mediated inhibition of CYP450 enzyme. Pediculosis [1G00] [42]
Methylscopolamine DM5VWOB Moderate Additive CNS depression effects by the combination of Meperidine and Methylscopolamine. Peptic ulcer [DA61] [14]
Levomepromazine DMIKFEL Moderate Additive CNS depression effects by the combination of Meperidine and Levomepromazine. Psychotic disorder [6A20-6A25] [16]
Fluphenazine DMIT8LX Major Additive CNS depression effects by the combination of Meperidine and Fluphenazine. Psychotic disorder [6A20-6A25] [43]
Triflupromazine DMKFQJP Major Additive CNS depression effects by the combination of Meperidine and Triflupromazine. Psychotic disorder [6A20-6A25] [13]
Quetiapine DM1N62C Major Additive CNS depression effects by the combination of Meperidine and Quetiapine. Schizophrenia [6A20] [43]
Mesoridazine DM2ZGAN Major Additive CNS depression effects by the combination of Meperidine and Mesoridazine. Schizophrenia [6A20] [43]
Thioridazine DM35M8J Major Additive CNS depression effects by the combination of Meperidine and Thioridazine. Schizophrenia [6A20] [13]
Aripiprazole DM3NUMH Major Additive CNS depression effects by the combination of Meperidine and Aripiprazole. Schizophrenia [6A20] [13]
Iloperidone DM6AUFY Major Additive CNS depression effects by the combination of Meperidine and Iloperidone. Schizophrenia [6A20] [13]
Paliperidone DM7NPJS Major Additive CNS depression effects by the combination of Meperidine and Paliperidone. Schizophrenia [6A20] [13]
Haloperidol DM96SE0 Major Additive CNS depression effects by the combination of Meperidine and Haloperidol. Schizophrenia [6A20] [13]
Perphenazine DMA4MRX Major Additive CNS depression effects by the combination of Meperidine and Perphenazine. Schizophrenia [6A20] [13]
Molindone DMAH70G Major Additive CNS depression effects by the combination of Meperidine and Molindone. Schizophrenia [6A20] [13]
Chlorpromazine DMBGZI3 Major Additive CNS depression effects by the combination of Meperidine and Chlorpromazine. Schizophrenia [6A20] [43]
Thiothixene DMDINC4 Major Additive CNS depression effects by the combination of Meperidine and Thiothixene. Schizophrenia [6A20] [43]
Trifluoperazine DMKBYWI Major Additive CNS depression effects by the combination of Meperidine and Trifluoperazine. Schizophrenia [6A20] [13]
Asenapine DMSQZE2 Major Additive CNS depression effects by the combination of Meperidine and Asenapine. Schizophrenia [6A20] [13]
Pimozide DMW83TP Major Additive CNS depression effects by the combination of Meperidine and Pimozide. Schizophrenia [6A20] [13]
Fentanyl DM8WAHT Major Additive CNS depression effects by the combination of Meperidine and Fentanyl. Sensation disturbance [MB40] [13]
Larotrectinib DM26CQR Moderate Decreased metabolism of Meperidine caused by Larotrectinib mediated inhibition of CYP450 enzyme. Solid tumour/cancer [2A00-2F9Z] [26]
Fostamatinib DM6AUHV Moderate Decreased clearance of Meperidine due to the transporter inhibition by Fostamatinib. Thrombocytopenia [3B64] [44]
Clopidogrel DMOL54H Moderate Altered absorption of Meperidine due to GI dynamics variation caused by Clopidogrel. Thrombosis [DB61-GB90] [35]
Tizanidine DMR2IQ4 Major Additive CNS depression effects by the combination of Meperidine and Tizanidine. Tonus and reflex abnormality [MB47] [13]
Atropine DMEN6X7 Moderate Additive antimotility effects by the combination of Meperidine and Atropine. Unspecific substance harmful effect [NE6Z] [14]
Methdilazine DMAUHQX Moderate Additive CNS depression effects by the combination of Meperidine and Methdilazine. Vasomotor/allergic rhinitis [CA08] [16]
Trimeprazine DMEMV9D Moderate Additive CNS depression effects by the combination of Meperidine and Trimeprazine. Vasomotor/allergic rhinitis [CA08] [45]
⏷ Show the Full List of 147 DDI Information of This Drug

Drug Inactive Ingredient(s) (DIG) and Formulation(s) of This Drug

DIG
DIG Name DIG ID PubChem CID Functional Classification
D&C red no. 27 E00381 83511 Colorant
Stearic acid E00079 5281 Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant
Sunset yellow FCF E00255 17730 Colorant
Calcium hydrogenphosphate E00294 24441 Diluent
Calcium sulfate anhydrous E00303 24497 Desiccant; Diluent
Carmellose sodium E00625 Not Available Disintegrant
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant
Povidone E00667 Not Available Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Silicon dioxide E00670 Not Available Anticaking agent; Opacifying agent; Viscosity-controlling agent
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Vinylpyrrolidone E00668 Not Available Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
⏷ Show the Full List of 12 Pharmaceutical Excipients of This Drug
Pharmaceutical Formulation
Formulation Name Drug Dosage Dosage Form Route
Meperidine 150 mg tablet 150 mg Oral Tablet Oral
Meperidine 75 mg tablet 75 mg Oral Tablet Oral
Meperidine 100 mg tablet 100 mg Oral Tablet Oral
Meperidine 50 mg tablet 50 mg Oral Tablet Oral
Jump to Detail Pharmaceutical Formulation Page of This Drug

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 BDDCS applied to over 900 drugs
3 Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
4 Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose
5 Meperidine, remifentanil and tramadol but not sufentanil interact with alpha(2)-adrenoceptors in alpha(2A)-, alpha(2B)- and alpha(2C)-adrenoceptor ... Eur J Pharmacol. 2008 Mar 17;582(1-3):70-7.
6 Opioids and efflux transporters. Part 3: P-glycoprotein substrate activity of 3-hydroxyl addition to meperidine analogs. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3638-40.
7 Is meperidine the drug that just won't die? J Pediatr Pharmacol Ther. 2011 Jul;16(3):167-9.
8 CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes. Drug Metab Dispos. 2004 Sep;32(9):930-6.
9 Impact of cytochrome P450 variation on meperidine N-demethylation to the neurotoxic metabolite normeperidine. Xenobiotica. 2020 Feb;50(2):209-222.
10 Insights into CYP2B6-mediated drug-drug interactions. Acta Pharm Sin B. 2016 Sep;6(5):413-425.
11 Product Information. Buprenex (buprenorphine). Reckitt and Colman Pharmaceutical, Richmond, VA.
12 Hansen BS, Dam M, Brandt J, et al "Influence of dextropropoxyphene on steady state serum levels and protein binding of three anti-epileptic drugs in man." Acta Neurol Scand 61 (1980): 357-67. [PMID: 6998251]
13 US Food and Drug Administration "FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines requires its strongest warning.".
14 Product Information. Apadaz (acetaminophen-benzhydrocodone). KemPharm, Inc, Coralville, IA.
15 Browne B, Linter S "Monoamine oxidase inhibitors and narcotic analgesics: a critical review of the implications for treatment." Br J Psychiatry 151 (1987): 210-2. [PMID: 2891392]
16 Lambertsen CJ, Wendel H, Longenhagen JB "The separate and combined respiratory effects of chlorpromazine and meperidine in normal men controlled at 46 mm Hg alveolar pCO2." J Pharmacol Exp Ther 131 (1961): 381-93. [PMID: 13758472]
17 Gilman AG, Rall TW, Nies AS, Taylor P, eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th ed." New York, NY: Pergamon Press Inc. (1990):.
18 US Food and Drug Administration "FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines requires its strongest warning.".
19 Achamallah NS "Visual hallucinations after combining fluoxetine and dextromethorphan ." Am J Psychiatry 149 (1992): 1406. [PMID: 1530079]
20 Bergeron L, Boule M, Perreault S "Serotonin toxicity associated with concomitant use of linezolid." Ann Pharmacother 39 (2005): 956-61. [PMID: 15827071]
21 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
22 Product Information. Piqray (alpelisib). Novartis Pharmaceuticals, East Hanover, NJ.
23 Ghoneim MM, Pandya H "Plasma protein binding of bupivacaine and its interaction with other drugs in man." Br J Anaesth 46 (1974): 435-8. [PMID: 4458761]
24 Gill SS, Wright EM, Reilly CS "Pharmacokinetic interaction of propofol and fentanyl: single bolus injection study." Br J Anaesth 65 (1990): 760-5. [PMID: 2265045]
25 Sturner WQ, Garriott JC "Deaths involving propoxyphene: a study of 41 cases over a two-year period." JAMA 223 (1973): 1125-30. [PMID: 4739371]
26 Cerner Multum, Inc. "Australian Product Information.".
27 Pond SM, Kretschzmar KM "Effect of phenytoin on meperidine clearance and normeperidine formation." Clin Pharmacol Ther 30 (1981): 680-6. [PMID: 7297025]
28 Eckhardt K, Ammon S, Hofmann U, Riebe A, Gugeler N, Mikus G "Gabapentin enhances the analgesic effect of morphine in healthy volunteers." Anesth Analg 91 (2000): 185-91. [PMID: 10866910]
29 Guay DR, Meatherall RC, Chalmers JL, Grahame GR "Cimetidine alters pethidine disposition in man." Br J Clin Pharmacol 18 (1984): 907-14. [PMID: 6529532]
30 Product Information. Alphagan (brimonidine ophthalmic). Allergan Inc, Irvine, CA.
31 Gannon RG, Pearsall W, Rowley R "Isoniazid, meperidine, and hypotension." Ann Intern Med 99 (1983): 415. [PMID: 6614704]
32 Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
33 Product Information. Zulresso (brexanolone). Sage Therapeutics, Inc., Cambridge, MA.
34 Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
35 Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
36 Product Information. Reglan (metoclopramide). Wyeth-Ayerst Laboratories, Philadelphia, PA.
37 Canadian Pharmacists Association.
38 Product Information. Wellbutrin XL (buPROPion). GlaxoSmithKline, Philadelphia, PA.
39 Chan BSH, Graudins A, Whyte IM, Dawson AH, Braitberg G, Duggin GG "Serotonin syndrome resulting from drug interactions." Med J Aust 169 (1998): 523-5. [PMID: 9861909]
40 Product Information. Belviq (lorcaserin). Eisai Inc, Teaneck, NJ.
41 Product Information. Artane (trihexyphenidyl). Lederle Laboratories, Wayne, NJ.
42 Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
43 Cerner Multum, Inc. "Canadian Product Information.".
44 Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
45 Hoffman JC, Smith TC "The respiratory effects of meperidine and propiomazine in man." Anesthesiology 32 (1970): 325-31. [PMID: 4392394]